[Tuberculous pericarditis]. 1980

D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas

UI MeSH Term Description Entries
D008297 Male Males
D010495 Pericarditis, Tuberculous INFLAMMATION of the sac surrounding the heart (PERICARDIUM) due to MYCOBACTERIUM TUBERCULOSIS infection. Pericarditis can lead to swelling (PERICARDIAL EFFUSION), compression of the heart (CARDIAC TAMPONADE), and preventing normal beating of the heart. Tuberculous Pericarditis,Pericarditides, Tuberculous,Tuberculous Pericarditides
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014381 Tuberculosis, Cardiovascular Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infection of MYCOBACTERIUM TUBERCULOSIS. Tuberculosis involvement may include the HEART; the BLOOD VESSELS; or the PERICARDIUM. Cardiovascular Tuberculosis,Cardiovascular Tuberculoses,Tuberculoses, Cardiovascular

Related Publications

D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
January 1996, Ryoikibetsu shokogun shirizu,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
January 2014, Biomedica : revista del Instituto Nacional de Salud,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
July 1963, Sbornik lekarsky,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
March 1952, Il Progresso medico,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
January 1985, Revista clinica espanola,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
January 1989, Plucne bolesti : casopis Udruzenja pneumoftiziologa Jugoslavije = the journal of Yugoslav Association of Phthisiology and Pneumology,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
December 2005, Circulation,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
December 1948, Edinburgh medical journal,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
November 1950, Journal des praticiens; revue generale de clinique et de therapeutique,
D Garfinkel, and I Hermoni, and Y Sidi, and D Aderka, and J Pinhas
January 1970, Proceedings of the Mine Medical Officers' Association,
Copied contents to your clipboard!